Tag: Sleep Apnea
Industry weighs potential impact of weight loss drugs
November 17, 2023Theresa Flaherty, Managing Editor
YARMOUTH, Maine – Respondents to a recent HME Newspoll aren’t quite sure what to make of the weight loss drug craze and whether or not it will impact demand for certain HME.
Nearly 40% of respondents say the drugs, which are known as GLP-1s and which include brand names like Ozempic and Wegovy, could reduce demand for CPAP devices, as obesity is among the most important risk factors for sleep apnea.
“Over time, I think this will have a huge impact on PAP devices...
Vivos announces deal with Lincare
October 25, 2023HME News Staff
LITTLETON, Colo. – Vivos Therapeutics, a medical technology company that makes oral appliances for patients suffering from mild-to-moderate obstructive sleep apnea and snoring in adults, has signed a distribution agreement with Lincare.
The agreement follows a successful a distribution pilot with Lincare and marks an important milestone in Vivos’ strategy to engage with leading durable medical equipment companies in the United States. Lincare will have a six-month exclusive deal...
Vivos appliance gets clinical trial
October 12, 2023HME News Staff
LITTLETON, Colo. – Vivos Therapeutics, a medical technology company focused on developing treatments for patients suffering from mild-to-moderate obstructive sleep apnea and snoring in adults, announced that its flagship daytime-nighttime appliance (DNA) will be tested in a clinical trial at Stanford Medicine. “We are extremely excited to be starting this trial at Stanford Medicine, which has been in the works for some time” said R. Kirk Huntsman, chairman and CEO of Vivos. “I...
Apnimed appoints Yee as senior exec
September 20, 2023HME News Staff
CAMBRIDGE, Mass. – Apnimed, a pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea and related disorders, has appointed John Yee, MD, MPH, as senior vice president of medical affairs. Dr. Yee will lead Apnimed’s efforts to engage and inform the clinical community about the company’s lead drug candidate AD109, as well as other pipeline assets, as they progress through clinical development toward commercial launch....
AASM president: Sleep apnea is more than just ‘annoying’ snoring
July 21, 2023Theresa Flaherty, Managing Editor
DARIEN, Ill. – When it comes to awareness of sleep apnea, the message is getting out there, but it’s not amplified enough, says Dr. James Rowley, the American Academy of Sleep Medicine’s new president.
“I think we need to keep reinforcing that message and getting people to think about talking to their primary care doctor,” said Rowley, who is currently transitioning to a new role as a professor of medicine at Rush University Medical Center in Chicago. “Even...
Star Sleep & Wellness assembles ‘dream team,’ opens five locations
July 19, 2023HME News Staff
DALLAS and FORT WORTH, Texas – Star Sleep & Wellness has recently opened five locations throughout the Dallas metroplex, in Dallas, Denton, Frisco, Irving and Plano, to offer comprehensive services to patients. Star Sleep & Wellness CEO Dr. Kent Smith has assembled a "dream team" of sleep specialists, including sleep physicians, a licensed psychologist, nurse practitioners, physician assistants and sleep dentists. "Star Sleep & Wellness is able to not only diagnose sleep disorders through testing...
Sleep therapy market: Keeping calm and carrying on
June 13, 2023Boone Lockard
Editor’s note: It’s been a busy year in the sleep market, as manufacturers rebound from supply chain issues that have plagued them since 2020 and new technologies have launched to increase patient compliance. Boone Lockard, director of VGM Respiratory, recently weighed in on what he’s currently seeing in this dynamic space.
On the challenges and opportunities in the sleep market
Opportunities:
The sleep market presents several significant opportunities...
Study: PAP adherence can reduce hospitalizations
June 8, 2023HME News Staff
INDIANAPOLIS – People with heart failure and obstructive sleep apnea can significantly reduce hospitalizations and ER visits, as well as related costs, by being adherent with PAP therapy, according to two recent studies.
The studies were supported by ResMed and presented at SLEEP 2023.
One study analyzed 1,472 people with OSA and systolic heart failure, with exactly half adherent on PAP therapy and half non-adherent. The adherent patients had 24% fewer ER visits and incurred...
VirtuOx participates in sleep screening initiative
May 23, 2023HME News Staff
GRAMBLING, La. – VirtuOx will participate in a national initiative to screen, test and treat obstructive sleep apnea in historically black colleges and universities (HBCUs) launched by Nexus Dental Systems. The initiative kicks off on May 22 with the Grambling State University Tigers football team, coaching staff and administrators, with screening for the broader university community beginning in the fall. “Grambling State is only the first stop on a national tour to bring needed care...
Sommetrics looks to former Philips exec to guide company through product launch
May 22, 2023HME News Staff
SAN DIEGO – Sommetrics has announced that John Frank, a former Philips exec, has been elected to its board of directors. As a senior executive and business group leader at Philips, Frank led global health technology organizations in sleep, respiratory care and cardiac monitoring services. Sommetrics says he was pivotal in establishing Philips as a leader in the home health care market with a digital care ecosystem aligned with best-in-class products for treating and monitoring cardiopulmonary...